These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 28634759)
1. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Pasin D; Cawley A; Bidny S; Fu S Anal Bioanal Chem; 2017 Oct; 409(25):5821-5836. PubMed ID: 28634759 [TBL] [Abstract][Full Text] [Related]
2. Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Mollerup CB; Dalsgaard PW; Mardal M; Linnet K Drug Test Anal; 2017 Jul; 9(7):1052-1061. PubMed ID: 27750404 [TBL] [Abstract][Full Text] [Related]
3. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples. Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082 [TBL] [Abstract][Full Text] [Related]
4. Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching. Montesano C; Vannutelli G; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M J Anal Toxicol; 2016 Sep; 40(7):519-28. PubMed ID: 27466313 [TBL] [Abstract][Full Text] [Related]
5. Addressing the challenges in forensic drug chemistry. Brandt SD; Kavanagh PV Drug Test Anal; 2017 Mar; 9(3):342-346. PubMed ID: 28103651 [No Abstract] [Full Text] [Related]
6. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS). Fagiola M; Hahn T; Avella J J Anal Toxicol; 2018 Oct; 42(8):562-569. PubMed ID: 30371846 [TBL] [Abstract][Full Text] [Related]
7. The Analytical Challenge in the Determination of Cathinones, Key-Players in the Worldwide Phenomenon of Novel Psychoactive Substances. Couto RAS; Gonçalves LM; Carvalho F; Rodrigues JA; Rodrigues CMP; Quinaz MB Crit Rev Anal Chem; 2018 Sep; 48(5):372-390. PubMed ID: 29437467 [TBL] [Abstract][Full Text] [Related]
8. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Strano Rossi S; Odoardi S; Gregori A; Peluso G; Ripani L; Ortar G; Serpelloni G; Romolo FS Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1904-16. PubMed ID: 25088134 [TBL] [Abstract][Full Text] [Related]
9. Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis. Rotolo MC; Klein J; Pacifici R; Busardo FP; Pichini S; Marchei E Curr Pharm Biotechnol; 2017; 18(10):834-839. PubMed ID: 29173161 [TBL] [Abstract][Full Text] [Related]
10. Developments in high-resolution mass spectrometric analyses of new psychoactive substances. Klingberg J; Keen B; Cawley A; Pasin D; Fu S Arch Toxicol; 2022 Apr; 96(4):949-967. PubMed ID: 35141767 [TBL] [Abstract][Full Text] [Related]
11. Application of a screening method for fentanyl and its analogues using UHPLC-QTOF-MS with data-independent acquisition (DIA) in MS Noble C; Weihe Dalsgaard P; Stybe Johansen S; Linnet K Drug Test Anal; 2018 Apr; 10(4):651-662. PubMed ID: 28834382 [TBL] [Abstract][Full Text] [Related]
12. Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution? Stephanson NN; Signell P; Helander A; Beck O J Mass Spectrom; 2017 Aug; 52(8):497-506. PubMed ID: 28493314 [TBL] [Abstract][Full Text] [Related]
13. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today? Meyer MR; Maurer HH Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833 [TBL] [Abstract][Full Text] [Related]
14. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Swortwood MJ; Ellefsen KN; Wohlfarth A; Diao X; Concheiro-Guisan M; Kronstrand R; Huestis MA Anal Bioanal Chem; 2016 Jul; 408(18):4845-56. PubMed ID: 27185540 [TBL] [Abstract][Full Text] [Related]
15. New challenges and innovation in forensic toxicology: focus on the "New Psychoactive Substances". Favretto D; Pascali JP; Tagliaro F J Chromatogr A; 2013 Apr; 1287():84-95. PubMed ID: 23332303 [TBL] [Abstract][Full Text] [Related]
16. A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data. Partridge E; Trobbiani S; Stockham P; Charlwood C; Kostakis C J Anal Toxicol; 2018 Nov; 42(9):655-660. PubMed ID: 29945197 [TBL] [Abstract][Full Text] [Related]
17. High-resolution mass spectrometry in toxicology: current status and future perspectives. Maurer HH; Meyer MR Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376 [TBL] [Abstract][Full Text] [Related]
18. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Ojanperä I; Kolmonen M; Pelander A Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167 [TBL] [Abstract][Full Text] [Related]
19. Return of the lysergamides. Part III: Analytical characterization of N Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Stratford A; Nichols DE; Halberstadt AL Drug Test Anal; 2017 Oct; 9(10):1641-1649. PubMed ID: 28342178 [TBL] [Abstract][Full Text] [Related]
20. [New psychoactive substances require a paradigm shift in drug testing in Denmark]. Breindahl T; Hindersson P; Leutscher PD; Kimergård A Ugeskr Laeger; 2018 Mar; 180(11):. PubMed ID: 29530235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]